Smith-Lemli-Opitz syndrome.
D000015:Abnormalities, Multiple; D001341:Autonomic Nervous System; D005149:Facial Expression; D005934:Glucagon / Q000627:therapeutic use; D006130:Growth Disorders; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy; D007223:Infant; D008607:Intellectual Disability; D008297:Male; D008831:Microcephaly; D009422:Nervous System Diseases / Q000150:complications; D013546:Sweating
D005934:Glucagon